Ischemia reperfusion injury promotes recurrence of hepatocellular carcinoma in fatty liver via ALOX12-12HETE-GPR31 signaling axis
Faji Yang(Nanjing Drum Tower Hospital), Xiaolei Shi(Nanjing Drum Tower Hospital)
Cited by 76
Related Papers
miR-27b synergizes with anticancer drugs via p53 activation and CYP1B1 suppression
|Cell Research|2015|99
The hypoxia conditioned mesenchymal stem cells promote hepatocellular carcinoma progression through YAP mediated lipogenesis reprogramming
|Journal of Experimental & Clinical Cancer Research|2019|81
SS‐31 Protects Liver from Ischemia‐Reperfusion Injury via Modulating Macrophage Polarization
|Oxidative Medicine and Cellular Longevity|2021|43
TNF<i>α</i>-Mediated Necroptosis Aggravates Ischemia-Reperfusion Injury in the Fatty Liver by Regulating the Inflammatory Response
|Oxidative Medicine and Cellular Longevity|2019|42
Inhibition of HMGB1 Suppresses Hepatocellular Carcinoma Progression via HIPK2-Mediated Autophagic Degradation of ZEB1
|Frontiers in Oncology|2021|33